Recombinant Human BMP-13 (B423-50ug)

Bone Morphogenetic Protein-13 (BMP-13) is a member of the transforming growth factor beta (TGF-beta) superfamily of growth factors that may regulate patterning of the ectoderm by interacting with bone morphogenetic proteins and control eye development. The biological actions of BMP-13 remain poorly understood. Expression of BMP-13 is predominantly seen in hypertrophic chondrocytes in regions of endochondral bone formation during development. BMP-13 in post natal articular cartilage suggests that this protein may function in an autocrine/paracrine way to regulate the growth and maintenance of articular cartilage. In addition to this BMP-13 has been shown to induce neotendon/neoligament formation when injected on a collagen carrier subcutaneously or intramuscularly. This indicates that BMP-13 may have therapeutic value for tendon or ligament healing following injury. At the amino acid sequence level, human and mouse GDF-6 are 99% identical. GDF-6 response is mediated by the formation of hetero-oligomeric complexes of type I (BMPR-IB) and type II (BMPR-II or Activin R-II) sereine/threonine kinase receptors, and the activation of Smad proteins.